With more money being plugged into battling antibiotic resistance, researchers have begun to consider synthetic biology as a new way to fight bacteria.
Moderna Therapeutics has began taking the steps to produce a cancer vaccine based on the growing volume of research on messenger RNA (mRNA).
In an attempt to make precision medicine the next mainstream, China are leading the way with Artificial Intelligence (AI).
Researchers have used CRISPR to genetically engineer a transgenic mosquitoe species, which could lead to the eventual eradication of a species.
After receiving $19 million in series A funding, the biotech is taking steps towards their first clinical trial for CRISPR-based antimicrobial drugs.
Arvinas has revealed expansion plans on an ongoing licensing deal with Genentech. The agreement is to develop new drugs using Arvinas’ PROTAC technology.
The FDA have cleared Cianna Medical’s breast tumour localisation system, one of the first to be cleared for long term use.
Keith Speights takes a look at four biotech companies that he believes are currently in the process of disrupting healthcare.
Researchers have answered a major key question in cancer research: Why is testicular cancer so responsive to chemotherapy, even after it metastasizes?
Novartis has revealed plans to collaborate with start-up, Homology Medicines to expand its programs in gene therapy and gene editing.